Cargando…
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease
Multiple system atrophy (MSA) is a neurodegenerative disease characterised by glial cytoplasmic inclusions (GCIs), containing α-synuclein. Mutated COQ2, encoding an enzyme essential for co-enzyme Q10 (CoQ10) biosynthesis, has been associated with MSA. CoQ10 is an electron carrier in the mitochondria...
Autores principales: | Foti, Sandrine C., Hargreaves, Iain, Carrington, Stephanie, Kiely, Aoife P., Houlden, Henry, Holton, Janice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484105/ https://www.ncbi.nlm.nih.gov/pubmed/31024027 http://dx.doi.org/10.1038/s41598-019-42902-7 |
Ejemplares similares
-
Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients
por: Schottlaender, Lucia V., et al.
Publicado: (2016) -
Immunohistochemical and Molecular Investigations Show Alteration in the Inflammatory Profile of Multiple System Atrophy Brain
por: Kiely, Aoife P, et al.
Publicado: (2018) -
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
por: Kiely, Aoife P., et al.
Publicado: (2013) -
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
por: Toomey, Christina E., et al.
Publicado: (2022) -
Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
por: Miki, Yasuo, et al.
Publicado: (2021)